These analogs significantly enhanced the accumulation and efficacy of chemotherapeutic agents (vincristine, colchicine, and paclitaxel) in P-gp-overexpressing cervical and colon cancer cells, resulting in up to a ninefold reversal of drug resistance, comparable to that of standard P-gp inhibitors such as verapamil. Here, PGP is linked to colonic neoplasm.